Yan Shangcheng, Shao Qiankun, Peng Wei, Cheng Ming, Liu Tianhua, Sheng Mengchao, Ren Rui, Chen Qiang, Gong Wei, Wu Yongyou
Department of Gastrointestinal Surgery, Second Affiliated Hospital of Soochow University, Suzhou, China.
Department of Gastroenterology and Minimally Invasive Surgery, Juntendo University Hospital, Tokyo, Japan.
J Gastrointest Oncol. 2024 Jun 30;15(3):908-920. doi: 10.21037/jgo-24-58. Epub 2024 Jun 20.
Studies on survival and prognostic factors in individuals with remnant gastric cancer (RGC) after gastric cancer (GC) are rare. It is debatable whether prognosis of RGC after GC is worse than that of only primary GC (OPGC). The objective of this study is to compare the survival outcomes between post-GC RGC and OPGC undergoing surgical resection and to identify the prognostic factors of disease-specific survival (DSS) for RGC.
We retrospectively collected data from the Surveillance, Epidemiology, and End Results (SEER) database among patients who underwent GC surgery in 1988-2020. Propensity score matching (PSM) was conducted to balance baseline characteristics. Kaplan-Meier (KM) survival analysis was performed to compare their overall survival (OS) and DSS. Multivariable Cox analyses were performed to identify the independent prognostic factors of DSS for post-GC RGC by estimating hazard ratios (HRs) with 95% confidence intervals (CIs).
There were 76 patients with RGC and 32,763 patients with OPGC included and analyzed. After balancing the baseline characteristics by PSM, no significant difference existed between OPGC and RGC groups in both OS (P=0.65) and DSS (P=0.28). Fixed-time analyses also showed no difference between the two groups for the 5-year (60.0%, RGC . 53.3%, OPGC, P=0.38) and 10-year DSS (56.7%, RGC . 48.3%, OPGC, P=0.34). Multivariable analysis revealed that area of lower income ($75,000+ . <$55,000, HR =0.21, 95% CI: 0.05-0.89, P=0.03), cardiac tumor [middle . cardia, HR =0.16, 95% CI: 0.03-0.77, P=0.02; distal . cardia, HR =0.10, 95% CI: 0.02-0.58, P=0.01; not otherwise specified (NOS) . cardia, HR =0.11, 95% CI: 0.03-0.51, P=0.004], deeper invasion (T3-4 . Tis-2, HR =5.19, 95% CI: 1.21-22.15, P=0.03), higher grade (G3 . G1-2, HR =7.35, 95% CI: 1.41-38.48, P=0.02) and not receiving chemotherapy (yes . no/unknown, HR =0.16, 95% CI: 0.04-0.60, P=0.007) were independent risk factors for postsurgical DSS in patients with post-GC RGC.
The prognosis of post-GC RGC was comparable to that of OPGC following surgical resection. The independent prognostic factors for RGC are similar to those established for OPGC. Our findings suggest that RGC following first GC might be the same entity to OPGC and curative resection should be considered in selected patients.
关于胃癌(GC)后残胃癌(RGC)患者的生存及预后因素的研究较少。GC后RGC的预后是否比单纯原发性GC(OPGC)更差仍存在争议。本研究的目的是比较接受手术切除的GC后RGC与OPGC的生存结局,并确定RGC疾病特异性生存(DSS)的预后因素。
我们回顾性收集了1988 - 2020年接受GC手术患者的监测、流行病学和最终结果(SEER)数据库中的数据。进行倾向评分匹配(PSM)以平衡基线特征。采用Kaplan - Meier(KM)生存分析比较其总生存(OS)和DSS。通过估计风险比(HRs)及95%置信区间(CIs)进行多变量Cox分析,以确定GC后RGC患者DSS的独立预后因素。
纳入并分析了76例RGC患者和32763例OPGC患者。通过PSM平衡基线特征后,OPGC组和RGC组在OS(P = 0.65)和DSS(P = 0.28)方面均无显著差异。固定时间分析也显示两组在5年(60.0%,RGC对53.3%,OPGC,P = 0.38)和10年DSS(56.7%,RGC对48.3%,OPGC,P = 0.34)方面无差异。多变量分析显示,低收入地区($75,000 +对<$55,000,HR = 0.21,95% CI:0.05 - 0.89,P = 0.03)、贲门部肿瘤[中部对贲门,HR = 0.16,95% CI:0.03 - 0.77,P = 0.02;远端对贲门,HR = 0.10,95% CI:0.02 - 0.58,P = 0.01;未另行说明(NOS)对贲门,HR = 0.11,95% CI:0.03 - 0.51,P = 0.004]、更深浸润(T3 - 4对Tis - 2,HR = 5.19,95% CI:1.21 - 22.15,P = 0.03)、更高分级(G3对G1 - 2,HR = 7.35,95% CI:1.41 - 38.48,P = 0.02)以及未接受化疗(是对否/未知,HR = 0.16,95% CI:0.04 - 0.60,P = 0.007)是GC后RGC患者术后DSS的独立危险因素。
GC后RGC手术切除后的预后与OPGC相当。RGC的独立预后因素与OPGC的既定因素相似。我们的研究结果表明,首次GC后的RGC可能与OPGC是同一实体,对于选定的患者应考虑进行根治性切除。